Adamantia L.
- Country
- Greece
- Department
- 5th Pathological University Clinic
Research Overview
- Evaluation of Long-Term Safety of Salbutamol Sulfate via MDI with Propellants HFA-152a and HFA-134a in Adults with Asthma
- Biomarker-Guided Early Clarithromycin Administration to Prevent Sepsis Progression in Community-Acquired Pneumonia: A Randomized Controlled Trial
- Efficacy and Safety of BI 1291583 in Patients with Bronchiectasis: A Phase III Randomized, Double-Blind, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 13 of 207 partner sites.
Specializations
Respiratory Medicine
The investigator specializes in the clinical evaluation of respiratory therapeutic interventions, with a particular focus on asthma management and treatment methodologies.
- Bronchodilator Delivery Systems
- Asthma Treatment Innovation
- Respiratory Drug Administration
Active investigation in inhalation device technologies and their clinical applications for respiratory conditions.
Therapeutic Delivery Systems
Expertise in evaluating metered-dose inhaler (MDI) technologies and their impact on therapeutic delivery in respiratory medicine.
- Propellant Technology Assessment
- Drug Delivery Optimization
- Device Safety Evaluation
Focused research on innovative propellant systems for respiratory medication delivery.
Clinical Safety Assessment
Specialized in conducting safety and tolerability evaluations of respiratory medications and delivery systems.
- Long-term Treatment Safety
- Patient Tolerance Studies
- Adult Population Research
Expertise in comparative safety assessments of respiratory therapeutic interventions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.